Ultragenyx Pharmaceutical Inc.RARENASDAQ
Loading
Cost of Revenue Over TimeExpanding
Percentile Rank93
3Y CAGR+56.5%
5Y CAGR+77.7%
Year-over-Year Change
Direct costs attributable to producing goods sold
3Y CAGR
+56.5%/yr
vs +123.0%/yr prior
5Y CAGR
+77.7%/yr
Recent deceleration
Acceleration
-66.4pp
Decelerating
Percentile
P93
Near historical high
vs 5Y Ago
17.7x
Strong expansion
Streak
5 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $108.66M | +41.6% |
| 2024 | $76.73M | +69.7% |
| 2023 | $45.21M | +59.6% |
| 2022 | $28.32M | +76.9% |
| 2021 | $16.01M | +161.2% |
| 2020 | $6.13M | -32.0% |
| 2019 | $9.01M | +686.0% |
| 2018 | $1.15M | +114500.0% |
| 2017 | $1000.00 | -100.0% |
| 2016 | $183.20M | - |